Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Quarterly Report 30 September 2012

28 April 201323 October 2012 by Karen Mobbs

Quarterly Report 30 September 2012

Categories 2012, Quarterly Reports
Biotron Limited to report new clinical data from BIT225 Hepatitis C Phase 2a trial in a late-breaking presentation at the AASLD 2012 annual conference
Annual report for the year ended 30 June 2012
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 23 November 2023        Legal Notices and Privacy
Cleantalk Pixel